| Total Market Value of Equity： | RMB 3.658 billion |
| Number of Issued Shares： | 398.052633 million shares |
| CPA | KPMG |
| Consolidated Information |
Cowealth Medical China Co., Ltd. is available from Shanghai Stock Exchange (Please enter the stock code：603122) |
| Date of Posting | 2023/5/12 |
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenues | 109,260 | 127,967 | 119,106 | 108,902 | 104,698 |
| Gross Profit | 22,611 | 25,756 | 25,017 | 22,462 | 23,092 |
| Operating Income | 6,658 | 11,494 | 10,986 | 10,397 | 9,275 |
| Consolidated Net Income Attributed to Stockholders of the Company | 4,719 | 8,272 | 8,023 | 7,255 | 6,714 |
| Gross Profit Margin | 20.69% | 20.13% | 21.00% | 20.63% | 22.06% |
| Operating Profit Margin | 6.09% | 8.98% | 9.22% | 9.55% | 8.86% |
| Net Profit Margin | 4.32% | 6.46% | 6.73% | 6.66% | 6.41% |
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Assets | 146,141 | 155,907 | 112,055 | 109,945 | 113,008 |
| Current Assets | 125,480 | 141,134 | 96,985 | 96,691 | 98,543 |
| Non-current assets | 20,661 | 14,772 | 15,070 | 13,253 | 14,465 |
| Total Liabilities | 29,249 | 38,049 | 32,478 | 38,243 | 34,068 |
| Current Liabilities | 28,573 | 36,155 | 30,161 | 37,510 | 33,021 |
| Non-current Liabilities | 677 | 1,894 | 2,317 | 732 | 1,046 |
| Shareholder Equity | 116,891 | 117,857 | 79,577 | 71,702 | 78,941 |
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,128 | -3,037 | 701 | 7,415 | -3,789 |
| Cash Flow from Investment Activities | -5,165 | -2,591 | -1,743 | 14,074 | -17,785 |
| Cash Flow from Financing Activities | -7,887 | 22,573 | -8,961 | -1,925 | 22,180 |
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| EPS | 0.12 | 0.22 | 0.27 | 0.24 | 0.22 |
| Cash dividend | 0.06 | 0.15 | 0.18 | 0.20 | 0.00 |
| Net assets per share | 3.67 | 3.92 | 3.75 | 3.68 | 3.79 |
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Asset-liability ratio | 20.01% | 24.41% | 28.98% | 34.78% | 30.15% |
| Return On Equity | 4.03% | 7.02% | 10.07% | 10.12% | 8.51% |
| Asset Turnover(time) | 0.72 | 0.96 | 1.07 | 0.98 | 1.09 |
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Issued Shares | 39,805 | 39,805 | 29,854 | 29,854 | 29,854 |
| Item | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 24,218 | 23,862 | 25,943 | 26,793 | 29,805 | 26,719 | 32,331 | 33,200 | 31,637 | 30,798 | 29,196 | 29,989 | 34,186 | 25,736 |
| Gross Profit | 4,457 | 5,232 | 5,355 | 5,387 | 6,334 | 5,535 | 6,598 | 6,190 | 6,769 | 6,201 | 7,352 | 5,900 | 6,754 | 5,012 |
| Operating Income | 2,116 | 1,018 | 266 | 1,931 | 3,042 | 1,418 | 4,016 | 2,328 | 2,988 | 2,163 | 3,452 | 2,523 | 3,284 | 1,728 |
| Consolidated Net Income Attributed to Stockholders of the Company | 1,539 | 713 | 311 | 1,315 | 2,170 | 922 | 2,847 | 1,774 | 2,137 | 1,514 | 2,643 | 1,857 | 2,111 | 1,412 |
| Gross Profit Margin | 18.40% | 21.93% | 20.64% | 20.11% | 21.25% | 20.72% | 20.41% | 18.64% | 21.39% | 20.13% | 25.18% | 19.67% | 19.76% | 19.47% |
| Operating Profit Margin | 8.74% | 4.27% | 1.03% | 7.21% | 10.21% | 5.31% | 12.42% | 7.01% | 9.44% | 7.02% | 11.82% | 8.41% | 9.61% | 6.71% |
| Net Profit Margin | 6.54% | 2.94% | 1.20% | 4.93% | 7.29% | 3.41% | 8.81% | 5.34% | 6.75% | 4.92% | 9.05% | 6.18% | 6.17% | 5.49% |
| Item | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 145,837 | 147,162 | 146,141 | 155,275 | 159,760 | 150,713 | 155,907 | 154,838 | 144,889 | 146,858 | 112,055 | 111,406 | 108,831 | 108,298 |
| Current Assets | 124,851 | 127,080 | 125,480 | 139,281 | 144,091 | 135,433 | 141,134 | 139,619 | 130,308 | 132,878 | 96,985 | 96,711 | 94,195 | 94,305 |
| Non-current assets | 20,986 | 20,082 | 20,661 | 15,994 | 15,669 | 15,280 | 14,772 | 15,220 | 14,581 | 13,980 | 15,070 | 14,695 | 14,636 | 13,993 |
| Total Liabilities | 29,069 | 29,622 | 29,249 | 38,515 | 44,211 | 32,135 | 38,049 | 39,557 | 32,229 | 29,868 | 32,478 | 34,319 | 33,641 | 34,983 |
| Current Liabilities | 28,723 | 29,056 | 28,573 | 37,671 | 43,254 | 30,339 | 36,155 | 37,762 | 30,350 | 27,794 | 30,161 | 31,893 | 32,433 | 33,563 |
| Non-current Liabilities | 346 | 566 | 677 | 844 | 957 | 1,796 | 1,894 | 1,795 | 1,879 | 2,074 | 2,317 | 2,426 | 1,208 | 1,421 |
| Shareholder Equity | 116,769 | 117,540 | 116,891 | 116,760 | 115,550 | 118,578 | 117,857 | 115,282 | 112,660 | 116,990 | 79,577 | 77,087 | 75,190 | 73,315 |
| Item | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2,932 | -5,271 | 6,477 | 2,306 | 3,744 | -11,399 | 15,726 | -9,953 | -2,103 | -6,705 | 7,013 | -1,546 | 8,192 | -12,959 |
| Cash Flow from Investment Activities | -930 | -679 | -5,727 | 1 | -30 | 591 | 2,686 | -807 | -4,224 | -246 | -1,403 | 61 | -231 | -170 |
| Cash Flow from Financing Activities | -6,044 | 5,732 | -11,707 | -2,323 | 3,077 | 3,066 | -6,187 | 4,416 | -8,283 | 32,627 | -334 | -3,081 | -5,058 | -488 |
| Item | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.04 | 0.02 | 0.01 | 0.03 | 0.06 | 0.02 | 0.08 | 0.04 | 0.05 | 0.05 | 0.09 | 0.06 | 0.07 | 0.05 |
| Cash dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 | 0.00 |
| Net assets per share | 3.66 | 3.70 | 3.67 | 3.90 | 4.01 | 3.79 | 3.92 | 3.89 | 3.64 | 3.69 | 3.75 | 3.73 | 3.65 | 3.63 |
| Item | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset-liability ratio | 19.93% | 20.13% | 20.01% | 24.80% | 27.67% | 21.32% | 24.41% | 25.55% | 22.24% | 20.34% | 28.98% | 30.81% | 30.91% | 32.30% |
| Return On Equity | 1.36% | 0.60% | 0.27% | 1.13% | 1.88% | 0.77% | 2.42% | 1.54% | 1.90% | 1.30% | 3.32% | 2.40% | 2.81% | 1.93% |
| Asset Turnover(time) | 0.63 | 0.64 | 0.69 | 0.69 | 0.78 | 0.72 | 0.97 | 1.00 | 1.00 | 0.97 | 1.05 | 1.07 | 1.28 | 0.92 |
| Item | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Issued Shares |
Scan
Follow
